Study Performance of The Plexur P™ Bone Void Filler Device in Patients Undergoing Iliac Crest Harvesting Procedures
Primary Purpose
Iliac Crest Harvesting Procedure-Bone Void Filler
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Plexur-P used as a Bone Void Filler in Iliac Crest Harvesting Procedures
Sponsored by
About this trial
This is an interventional treatment trial for Iliac Crest Harvesting Procedure-Bone Void Filler focused on measuring Bone Void Filler, Iliac Crest Bone Void Filler, Back Surgery and Autograft Bone, Autograft Bone, Allograft Bone
Eligibility Criteria
Inclusion Criteria:
- The patient is at least 18 yrs old.
- The patient requires an iliac crest harvesting procedure.
- The patient has signed an Informed Consent, approved by the IRB.
Exclusion Criteria:
- Patient is less than 18 years old.
- Patient presents with a bony void or gap in an area other than the iliac crest and/or has an infection present at the (operative) site.
- Insulin dependent diabetics and/or in the opinion of the investigator, has poorly controlled non-insulin dependent diabetes.
- The patient is a smoker.
- The patient is mentally compromised (e.g., currently being treated from a psychiatric disorder, senile dementia, Alzheimer's disease, etc.) and/or in the opinion of the investigator, is not likely to complete follow up visits;
- The patient has a bleeding disorder of any etiology, severe vascular or neurological disease;
- The patient has hypercalcemia and/or severe degenerative bone disease;
- The patient has a history of long term steroid use;
- The patient requires immunosuppressive therapy;
- The patient has a history of drug or alcohol abuse that may interfere with his/her ability to provide written informed consent;
- The patient is pregnant at the time of study entry or may likely become pregnant during the course of study participation;
- The subject has an implanted device, which is incompatible with the use of imaging equipment;
- The patient has an allergy to one of the components of the investigational device;
- The patient has renal insufficiency;
- The patient has a terminal illness.
Sites / Locations
- Hospital for Special Surgery
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Plexur-P Bone Void Filler
Arm Description
Single arm. Open Label.
Outcomes
Primary Outcome Measures
Number of Participants With Reconstitution of Bone Growth in the Iliac Crest Bone Void Determined by an Independent Radiologist
Reconstitution of bone growth was determined by an independent radiologist based on bony ingrowth and absence of a gap according to the following criteria:
Absent: limited or no bone mineralization visualized at the defect site; extensive areas of radiolucency.
Mild: identifiable bone mineralization and coalescence of the bone graft mass of < 50% of the defect site.
Moderate: identifiable bone mineralization and coalescence of the bone graft mass over > 50% of the defect site; some remaining unmineralized areas of radiolucency; limited evidence of partial bone remodeling and trabeculation.
Extensive: > 75% of bone mineralization over the defect site showing a contiguous and completely coalesced bone graft mass with confluent trabecular pattern.
Secondary Outcome Measures
General Health Status
The general health status was assessed by Medical Outcomes Study 36-Item Short Form Health Survey (SF-36v2). The SF-36v2 questionnaire contains 36 questions pertaining to eight subscales of health status. These eight subscales can be summarized as relating to either physical health or mental health. The physical component summary (PCS) is based primarily on the physical functioning, role-physical, bodily pain, and general health scales of the SF-36v2 survey. The mental component summary (MCS) encompasses vitality, social functioning, role-emotional, and mental health scales. The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life.
Oswestry Disability Index
The Oswestry Disability Index (ODI) is an internationally validated questionnaire consisting of ten sets of statements which focus on pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sex life, social life, and ability to travel. ODI scores are in a range of 0 to 100, with a lower score indicating less pain and disability and higher scores indicating more pain and disability.
Pain Status Assessed by Visual Analog Scale (VAS)
The visual analog scale (VAS) was used for assessing pain status in the body locations of back/neck, left leg/arm, and right arm/leg. Subjects were asked to rate their perception of pain in VAS, generated by the Osteotech Clinical Department. The scale from 1 to 5 represented the pain levels at none, mild, average, severe, and extreme.
Surgical Related Outcome--locations of Iliac Crest Bone Harvest
Surgical outcome-the Amount of Cancellous Bone Harvested
Surgical Outcome--operative Time
Surgical Outcome--blood Loss
Surgical Outcome--length of Hospital Stay
Surgical Outcome- the Amount of Plexur™ P Product Utilized for Filling Void
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00837473
Brief Title
Study Performance of The Plexur P™ Bone Void Filler Device in Patients Undergoing Iliac Crest Harvesting Procedures
Official Title
A Prospective Pilot Study on the Performance of The Plexur P™ Bone Void Filler
Study Type
Interventional
2. Study Status
Record Verification Date
September 2012
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
March 2011 (Actual)
Study Completion Date
October 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Osteotech, Inc
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine if Plexur P grows bone in the iliac crest (where bone was removed or "harvested") for the back surgery.
The study will be focusing on patients who require back surgery. Often additional bone is required from the hip of the patient (iliac crest). When bone removed from the hip, a "void" is often created. This "void" will be filled in with Osteotech's Plexur P product.
Detailed Description
This prospective trial is designed to evaluate the ability of the Plexur P device (bone void filler) to reconstitute the iliac crest in patients requiring iliac crest bone harvesting procedures at one single study site.
Plexur P Bone Void Filler is:
A biocomposite of mineralized cortical allograft bone fibers and polylactide-co-glycolide co-polymer.
Designed to fill bony voids or gaps of the skeletal system that are not intrinsic to the stability of the bony structure.
Porosity is introduced into the Plexur P Biocomposites to create a cancellous-like structure that provides a scaffold for bone growth.
In addition:
Patients will be screened for study eligibility based on the need for iliac crest bone harvesting.
Fifteen (15) eligible patients will be enrolled and will have an iliac crest harvesting defect backfilled with Plexur P to repair the iliac crest defect.
As a part of routine follow up care, patient related outcomes including measurements of pain severity and pain relief will be determined using patient (IRB approved) questionnaires.
Radiographic analysis will also be used to determine amount of bony ingrowth of the Plexur P device.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Iliac Crest Harvesting Procedure-Bone Void Filler
Keywords
Bone Void Filler, Iliac Crest Bone Void Filler, Back Surgery and Autograft Bone, Autograft Bone, Allograft Bone
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Plexur-P Bone Void Filler
Arm Type
Other
Arm Description
Single arm. Open Label.
Intervention Type
Device
Intervention Name(s)
Plexur-P used as a Bone Void Filler in Iliac Crest Harvesting Procedures
Intervention Description
Plexur-P used as a Bone Void Filler in Iliac Crest Harvesting Procedures
Primary Outcome Measure Information:
Title
Number of Participants With Reconstitution of Bone Growth in the Iliac Crest Bone Void Determined by an Independent Radiologist
Description
Reconstitution of bone growth was determined by an independent radiologist based on bony ingrowth and absence of a gap according to the following criteria:
Absent: limited or no bone mineralization visualized at the defect site; extensive areas of radiolucency.
Mild: identifiable bone mineralization and coalescence of the bone graft mass of < 50% of the defect site.
Moderate: identifiable bone mineralization and coalescence of the bone graft mass over > 50% of the defect site; some remaining unmineralized areas of radiolucency; limited evidence of partial bone remodeling and trabeculation.
Extensive: > 75% of bone mineralization over the defect site showing a contiguous and completely coalesced bone graft mass with confluent trabecular pattern.
Time Frame
6 wks, 3 mths, 6 mths 12 mths, and 24 mths
Secondary Outcome Measure Information:
Title
General Health Status
Description
The general health status was assessed by Medical Outcomes Study 36-Item Short Form Health Survey (SF-36v2). The SF-36v2 questionnaire contains 36 questions pertaining to eight subscales of health status. These eight subscales can be summarized as relating to either physical health or mental health. The physical component summary (PCS) is based primarily on the physical functioning, role-physical, bodily pain, and general health scales of the SF-36v2 survey. The mental component summary (MCS) encompasses vitality, social functioning, role-emotional, and mental health scales. The score for PCS and MCS is between 0 and 100, with higher scores denoting better quality of life.
Time Frame
Baseline, 6 wks, 3 mths, 6 mths, 12 mths, and 24 mths
Title
Oswestry Disability Index
Description
The Oswestry Disability Index (ODI) is an internationally validated questionnaire consisting of ten sets of statements which focus on pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sex life, social life, and ability to travel. ODI scores are in a range of 0 to 100, with a lower score indicating less pain and disability and higher scores indicating more pain and disability.
Time Frame
Baseline, 6 wks, 3 mths, 6 mths, 12 mths, and 24 mths
Title
Pain Status Assessed by Visual Analog Scale (VAS)
Description
The visual analog scale (VAS) was used for assessing pain status in the body locations of back/neck, left leg/arm, and right arm/leg. Subjects were asked to rate their perception of pain in VAS, generated by the Osteotech Clinical Department. The scale from 1 to 5 represented the pain levels at none, mild, average, severe, and extreme.
Time Frame
Baseline, 6 wks, 3 mths, 6 mths, 12 mths, and 24 mths
Title
Surgical Related Outcome--locations of Iliac Crest Bone Harvest
Time Frame
During the time of operation, a range of 2.5-8.5 hrs
Title
Surgical outcome-the Amount of Cancellous Bone Harvested
Time Frame
During the time of operation, a range of 2.5-8.5 hrs
Title
Surgical Outcome--operative Time
Time Frame
The time of operation, a range of 2.5-8.5 hrs
Title
Surgical Outcome--blood Loss
Time Frame
During the time of operation, a range of 2.5-8.5 hrs
Title
Surgical Outcome--length of Hospital Stay
Time Frame
From admission to discharge, a range of 2 to 20 days
Title
Surgical Outcome- the Amount of Plexur™ P Product Utilized for Filling Void
Time Frame
During the time of operation, a range of 2.5-8.5 hrs
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The patient is at least 18 yrs old.
The patient requires an iliac crest harvesting procedure.
The patient has signed an Informed Consent, approved by the IRB.
Exclusion Criteria:
Patient is less than 18 years old.
Patient presents with a bony void or gap in an area other than the iliac crest and/or has an infection present at the (operative) site.
Insulin dependent diabetics and/or in the opinion of the investigator, has poorly controlled non-insulin dependent diabetes.
The patient is a smoker.
The patient is mentally compromised (e.g., currently being treated from a psychiatric disorder, senile dementia, Alzheimer's disease, etc.) and/or in the opinion of the investigator, is not likely to complete follow up visits;
The patient has a bleeding disorder of any etiology, severe vascular or neurological disease;
The patient has hypercalcemia and/or severe degenerative bone disease;
The patient has a history of long term steroid use;
The patient requires immunosuppressive therapy;
The patient has a history of drug or alcohol abuse that may interfere with his/her ability to provide written informed consent;
The patient is pregnant at the time of study entry or may likely become pregnant during the course of study participation;
The subject has an implanted device, which is incompatible with the use of imaging equipment;
The patient has an allergy to one of the components of the investigational device;
The patient has renal insufficiency;
The patient has a terminal illness.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oheneba Boachie-Adijei, MD
Organizational Affiliation
Hospital for Special Surgery, New York
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital for Special Surgery
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Study Performance of The Plexur P™ Bone Void Filler Device in Patients Undergoing Iliac Crest Harvesting Procedures
We'll reach out to this number within 24 hrs